16th May 201819:00 - 20:15
Click here for Prescribing Information
This promotional meeting is organised and fully funded by MSD. MSD products will be discussed at the... Learn more »
|
Simponi (Golimumab) is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies.
|
Click here for Prescribing Information
Simponi (Golimumab) in Ulcerative Colitis: Sharing Real World Evidence and Experience
This promotional meeting is organised and fully funded by MSD. MSD products will be discussed at the... Learn more »